ACAD
ACAD
NASDAQ · Biotechnology

Acadia Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$22.40
-0.16 (-0.71%)
As of May 9, 1:21 AM ET ·
Analyst Consensus
Strong Buy
27
Analysts
High
Coverage
Buy 21 78%
Hold 5 19%
Sell 1 4%
Price Target
Analyst Price Target -20.1% upside
Low Target $12.70
Average Target $17.90
High Target $23.84
Current Price $22.40
Current
$22.40
Target
$17.90
$12.70 $17.90 avg $23.84
Scenario Analysis
Bear Case
$12.70
-43.3%
Low target
Base Case
$17.90
-20.1%
Avg target
Bull Case
$23.84
+6.4%
High target
Risk/Reward
0.1x
Unfavorable
Price in Context
52-Week High
$28.35
-21.0% from high
52-Week Low
$14.45
+55.0% from low
50-Day SMA
$25.91
-13.5% vs SMA
200-Day SMA
$23.44
-4.4% vs SMA
RSI (14)
42.4
Neutral
Target vs 52W High
$17.90
-36.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 72% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 26 96% $143.40 +41.5%